AcuteEffectofaSingleFunctionalNeurologyInterventiononMuscularTriggerPoint

Myofascial trigger points (MTrPs) are hyperirritable spots within skeletal muscle that cause significant pain, dysfunction, and reduced quality of life. These tender nodules are extremely common, particularly in the upper trapezius muscle, and contribute to chronic musculoskeletal pain conditions. While various treatments exist—including manual therapy, dry needling, trigger point injections, and pharmacological approaches—these interventions often provide only temporary relief, may be invasive, or require multiple sessions to achieve meaningful results. There remains a need for effective, non-invasive treatments that can rapidly reduce pain and improve muscle function.

Functional neurology represents an emerging approach that targets brain-based pain modulation mechanisms rather than focusing solely on local tissue changes. This study addresses whether a single session of functional neurology intervention can acutely reduce pain sensitivity and improve blood flow in individuals with active trigger points in the upper trapezius muscle.

The researchers conducted a randomized controlled trial with 63 healthy volunteers who had an active trigger point in the upper trapezius muscle confirmed by a professional physiotherapist. Participants were randomly assigned to either an experimental group (30 participants: 10 female, 20 male; mean age 29.5 years) or a control group (33 participants: 12 female, 21 male; mean age 30.1 years). Both groups underwent identical pre- and post-assessment procedures, separated by 5 minutes. Only the experimental group received the functional neurology intervention during this interval.

The 10-minute functional neurology intervention consisted of three sequential phases: (1) sensory stimulation with calibrated vibration (128 Hz) applied over the trigger point for 3 minutes; (2) blink reflex activation using controlled visual and tactile stimuli for 3 minutes; and (3) proprioceptive modulation involving isometric contractions and rapid release movements for 4 minutes. The control group received no intervention between assessments.

Outcome measures included pressure pain threshold (PPT) measured with a manual algometer at the trigger point, and peripheral vascular response assessed using infrared thermography at six anatomical points around the neck and upper back region. Evaluators were blinded to group assignments. Statistical analysis used dependent and independent t-tests with significance set at p<0.05.

The experimental group demonstrated a significant 46.4% increase in pressure pain threshold after the single functional neurology session, with mean PPT rising from 5.6±1.8 kg/cm² to 8.2±3.2 kg/cm² (t=-11.74, p<0.001, Cohen's d=1.25, 95% CI [1.89, 3.52]). This represents a large effect size. In contrast, the control group showed negligible change from 5.8±2.0 to 5.9±1.8 kg/cm² (1.7% change; t=1.09, p=0.282, d=0.05). Between-group comparison confirmed a significant post-intervention difference (t=3.931, p<0.001).

Thermographic analysis revealed significant improvements in peripheral vascular response in the experimental group, with increased skin temperatures across multiple measurement points. Notable changes included: posterior EI1 minimum temperature increase of 2.3% (t=-15.23, p<0.001); posterior EI2 minimum temperature increase of 2.4% (t=-6.91, p<0.001); and lateral EI3 maximum temperature increase of 1.9% (t=-3.62, p=0.001). The control group showed no significant thermographic changes, with all p-values exceeding 0.05. No adverse effects were reported from the intervention.

These findings suggest that functional neurology interventions may offer a promising non-invasive alternative for rapidly reducing pain sensitivity in myofascial trigger points. The substantial 46.4% increase in pressure pain threshold after a single 10-minute session—substantially exceeding established minimal detectable change thresholds of 0.45-0.62 kg/cm²—indicates both statistical and clinical significance. The improved peripheral vascular response, evidenced by increased skin temperatures, suggests enhanced local blood flow that may help reverse the ischemic conditions characteristic of trigger points.

For patients, this approach could provide immediate pain relief without the invasiveness of dry needling or injections, and without medication side effects. For clinicians, functional neurology techniques could be incorporated as an adjunct or alternative to traditional manual therapy, particularly for patients who are needle-averse or seeking drug-free pain management. However, the study's limitations—including no follow-up period, no sham control group, and relatively small sample—mean that questions remain about the durability of effects, the contribution of placebo mechanisms, and generalizability to broader populations including those with chronic pain conditions. Future research with larger samples, sham controls, and longitudinal follow-up is needed to confirm these initial promising results and establish optimal treatment protocols.